September 21-22, 2026 | Washington, D.C. Gaylord National harbor convention center and hotel The bioeconomy is increasingly constrained by execution at scale. The United States leads in industrial biotechnology discovery and early innovation but has struggled to consistently translate that advantage into deployed, commercial capacity. Projects stall between pilot and production, constrained by infrastructure, financing,…

Continue Reading